Moreover, IPF fibroblasts were treated with Pentostatin, an inhibitor of ADAR, and downregulation of pri-miRLet-7d (p < 0.0001) expression was observed with an upregulation of Let-7d (p < 0.0001) (Figure S2). Here, ADAR is linked to idiopathic pulmonary fibrosis.